Date published: 2025-12-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

Tom1L-1 Inhibitors

Tom1L-1 inhibitors belong to a class of chemical compounds designed to modulate the activity of the Tom1-like protein 1 (Tom1L-1), a member of the Tom1 family of proteins. These inhibitors are primarily utilized in laboratory research settings to investigate the biological functions and molecular pathways associated with Tom1L-1. Tom1L-1 is a cytoplasmic protein known to play crucial roles in cellular processes, particularly in endosomal trafficking and protein sorting within the cell. It functions as an adapter protein, facilitating interactions between membrane-associated proteins and downstream signaling molecules. By inhibiting Tom1L-1, researchers aim to gain insights into its regulatory functions and the consequences of its perturbation on various cellular processes.

The mechanism of action of Tom1L-1 inhibitors typically involves interfering with the binding or activity of Tom1L-1 within the cell. These inhibitors can function by directly binding to Tom1L-1, thus blocking its interactions with target proteins, or by disrupting the formation of protein complexes involving Tom1L-1. This interference can lead to altered endosomal trafficking patterns, affecting the sorting and trafficking of cargo proteins within the endocytic pathway. By studying the effects of Tom1L-1 inhibition, researchers aim to unravel its role in cellular homeostasis and disease processes. Tom1L-1 inhibitors are valuable tools in deciphering the intricate mechanisms underlying endosomal dynamics, vesicle trafficking, and protein sorting, contributing to our broader understanding of fundamental cellular biology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Aspirin

50-78-2sc-202471
sc-202471A
5 g
50 g
$20.00
$41.00
4
(1)

Inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis and inflammation.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

Targets tyrosine kinases, especially BCR-ABL, to inhibit cell proliferation in chronic myeloid leukemia (CML).

Omeprazole

73590-58-6sc-202265
50 mg
$66.00
4
(1)

Proton pump inhibitor that blocks gastric acid production by inhibiting the H+/K+ ATPase enzyme in parietal cells.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Inhibits multiple kinases, including RAF and VEGFR, to disrupt cancer cell signaling and angiogenesis.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$92.00
$209.00
33
(5)

Inhibits dihydrofolate reductase (DHFR), disrupting DNA synthesis and cell division in rapidly dividing cells.

Tamoxifen

10540-29-1sc-208414
2.5 g
$256.00
18
(2)

Selective estrogen receptor modulator (SERM) used in breast cancer therapy by blocking estrogen receptor signaling.

Metformin

657-24-9sc-507370
10 mg
$77.00
2
(0)

Activates AMP-activated protein kinase (AMPK) to lower blood glucose levels and improve insulin sensitivity.

Ritonavir

155213-67-5sc-208310
10 mg
$122.00
7
(1)

Protease inhibitor used for HIV/AIDS by inhibiting the HIV-1 protease enzyme, blocking viral replication.

Allopurinol

315-30-0sc-207272
25 g
$128.00
(0)

Inhibits xanthine oxidase, reducing uric acid production and used for gout and hyperuricemia.

Ciprofloxacin

85721-33-1sc-217900
1 g
$42.00
8
(1)

Inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication and transcription in bacteria.